Nano Bio Technology Fardanegar (NBTF)

nbtf.ir

Nano Bio Technology Fardanegar Cooperative Company (NBTF) is a knowledge-based company active in the fields of biotechnology, nano biotechnology, and in particular the production of nano particles and pharmaceutical nano carriers. The Company Started its activities on 2014 in the field of new sciences, especially in the field of Nano Biotechnology.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

HOVIONE EXPANDS DRUG PRODUCT OFFERING WITH A NEW MANUFACTURING LINE DEDICATED TO CONTINUOUS TABLETING

Hovione | September 07, 2022

news image

Hovione, the leader in spray drying and particle engineering, announced that it has expanded its continuous manufacturing offering and services. A new state-of-the-art continuous manufacturing facility is now coming online at the Loures site in Portugal. In addition, to support Hovione's commitment to providing access and services for continuous tableting, Hovione has further strengthened its capabilities by establishing a highly experienced multi-disciplinary global team in continuous table...

Read More

Business Insights

SS&C PARTNERS WITH XCENTUATE TO SUPPORT CUSTOMER DIGITAL TRANSFORMATION JOURNEYS

SS&C | June 23, 2022

news image

SS&C Technologies Holdings, Inc. announced a new partnership in the EMEA and APAC regions with Xcentuate, an award-winning international provider of digital productivity and performance solutions to the financial services, agricultural, pharma and public sectors. The partnership follows SS&C's recent acquisition of Blue Prism, the leading Robotic Process Automation provider, further demonstrating its commitment to the intelligent automation solutions market. Xcentuate,...

Read More

Pharma Tech

PALATIN ANNOUNCES INTENT TO EFFECT REVERSE STOCK SPLIT

Palatin Technologies, Inc. | August 20, 2022

news image

Palatin Technologies, Inc. a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, today announced that it intends to effect a 1-for-25 reverse split of its issued and outstanding common stock. The Reverse Stock Split will become effective as of 5:00 p.m. Eastern Time on August 30, 2022 and the Company's common stock is expected to begin trading on a split-adjusted basis when t...

Read More

Business Insights

ALR TECHNOLOGIES COMPLETES DEFINITIVE MANUFACTURING AGREEMENT WITH INFINOVO MEDICAL FOR THE GLUCURVE PET CGM HARDWARE

ALR Technologies | June 30, 2022

news image

ALR Technologies SG Pte. Ltd the diabetes management company, announces the completion of a definitive manufacturing agreement with Infinovo Medical Co. Ltd to manufacture and supply the Continuous Glucose Monitor hardware that will be utilized as part of the ALRT GluCurve Pet CGM. The Manufacturing Agreement gives ALRT the exclusive global rights to distribute the Infinovo CGM hardware for the animal health market, providing long-term production and supply. Subject to the satisfaction of all cl...

Read More
news image

Business Insights

HOVIONE EXPANDS DRUG PRODUCT OFFERING WITH A NEW MANUFACTURING LINE DEDICATED TO CONTINUOUS TABLETING

Hovione | September 07, 2022

Hovione, the leader in spray drying and particle engineering, announced that it has expanded its continuous manufacturing offering and services. A new state-of-the-art continuous manufacturing facility is now coming online at the Loures site in Portugal. In addition, to support Hovione's commitment to providing access and services for continuous tableting, Hovione has further strengthened its capabilities by establishing a highly experienced multi-disciplinary global team in continuous table...

Read More
news image

Business Insights

SS&C PARTNERS WITH XCENTUATE TO SUPPORT CUSTOMER DIGITAL TRANSFORMATION JOURNEYS

SS&C | June 23, 2022

SS&C Technologies Holdings, Inc. announced a new partnership in the EMEA and APAC regions with Xcentuate, an award-winning international provider of digital productivity and performance solutions to the financial services, agricultural, pharma and public sectors. The partnership follows SS&C's recent acquisition of Blue Prism, the leading Robotic Process Automation provider, further demonstrating its commitment to the intelligent automation solutions market. Xcentuate,...

Read More
news image

Pharma Tech

PALATIN ANNOUNCES INTENT TO EFFECT REVERSE STOCK SPLIT

Palatin Technologies, Inc. | August 20, 2022

Palatin Technologies, Inc. a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems, today announced that it intends to effect a 1-for-25 reverse split of its issued and outstanding common stock. The Reverse Stock Split will become effective as of 5:00 p.m. Eastern Time on August 30, 2022 and the Company's common stock is expected to begin trading on a split-adjusted basis when t...

Read More
news image

Business Insights

ALR TECHNOLOGIES COMPLETES DEFINITIVE MANUFACTURING AGREEMENT WITH INFINOVO MEDICAL FOR THE GLUCURVE PET CGM HARDWARE

ALR Technologies | June 30, 2022

ALR Technologies SG Pte. Ltd the diabetes management company, announces the completion of a definitive manufacturing agreement with Infinovo Medical Co. Ltd to manufacture and supply the Continuous Glucose Monitor hardware that will be utilized as part of the ALRT GluCurve Pet CGM. The Manufacturing Agreement gives ALRT the exclusive global rights to distribute the Infinovo CGM hardware for the animal health market, providing long-term production and supply. Subject to the satisfaction of all cl...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us